Inhibrx Biosciences stock surges after phase I/II CRC data of ozekibart show strong response rates and durable benefit, ...

Investigators explored the association between income and patient- and treatment characteristics, diagnosis through screening, and survival of patients with synchronous metastasized CRC.

Phase II Trial of Nivolumab Plus Doxorubicin, Vinblastine, Dacarbazine as Frontline Therapy in Older Adults With Hodgkin Lymphoma Colorectal cancer (CRC) remains a major global health burden, being ...

Researchers from Pusan National University develop a new strategy for selective local therapy against colorectal cancer. They used a pH-sensitive alginate matrix to shield the drug from exposure to ...

(A) Schematic diagram of Ce6-GFFY synthesis. DCC, N, N0-dicyclohexylcarbodiimide; DMAP, 4-dimethylaminopyridine; CH2CL2, dichloromethane. (B) The size distribution of Ce6-GFFY macroparticles was ...

Bevacizumab is a core component of CRC therapy across multiple lines of treatment, and we anticipate this combination data will unlock broad additional potential. Beyond CRC, we continue to see ...

An updated analysis performed by the Women’s Health Initiative revealed that menopausal hormone therapy with estrogen and progestin can significantly increase a woman’s risk of death from several ...

The antibody-drug conjugate trastuzumab deruxtecan (T-DXd, Enhertu) proved active in a phase II study of advanced HER2-positive colorectal cancer (CRC). Almost 40% of patients treated with the ...

Cantargia AB (Publ) (Nasdaq Stockholm:CANTA) today reported that the rationale and study design of the phase 1b/2 clinical trial investigating nadunolimab in combination with immune-checkpoint ...

Colorectal cancer (CRC) is a highly malignant disease that readily metastasizes to vital organs. Many strategies have been employed for clinical CRC therapy. However, current treatments face ...